Serositis
MONDO:0043786Inflammation of a serous membrane.
Also known as: inflammation of serous membrane, serositis, serous membrane inflammation, Serositides
62 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Can a common steroid stop lung fluid from coming back?
Disease control Recruiting nowThis pilot study tests whether the steroid prednisone can prevent recurrent pleural effusions (fluid buildup around the lungs) in people with non-specific pleuritis. Forty adults will be randomly assigned to take prednisone daily for 4 weeks or receive no steroid. The study lasts…
Phase: EARLY_PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Personalized antibody therapy could tame deadly gut infections
Disease control Recruiting nowThis study tests whether giving a personalized dose of Pentaglobin (an antibody treatment) after surgery helps people with severe abdominal infection (peritonitis) and sepsis recover better. Researchers will enroll 200 patients and track organ failure and survival. The goal is to…
Phase: PHASE2 • Sponsor: RWTH Aachen University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Stoma or no stoma? new trial tests safer surgery for bowel infections
Disease control Recruiting nowThis study looks at two ways to treat severe peritonitis caused by a burst diverticulitis pocket. Both involve removing the diseased part of the colon and reconnecting the bowel. One group also gets a temporary stoma (a bag on the belly) to protect the new connection, while the o…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New PET tracer aims to reveal hidden inflammation in cancer patients
Diagnosis Recruiting nowThis early-stage study tests a new imaging agent called 18F-4FN for PET scans to safely detect inflammation in the body. It involves 55 adults with cancer who are on immunotherapy or have suspected inflammation. The goal is to see if this agent can highlight areas of inflammation…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
New microscope technique aims to sharpen diagnosis of mysterious chest fluid
Diagnosis Recruiting nowThis study tests whether using a special microscope (confocal laser endomicroscopy) during a chest camera procedure can better diagnose unexplained pleural disease. About 158 adults with fluid around the lungs that standard tests couldn't diagnose will be randomly assigned to get…
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New DNA test could spot hidden TB in chest fluid, reducing invasive procedures
Diagnosis Recruiting nowThis study is testing a new laboratory method that looks for DNA fragments from tuberculosis bacteria in fluid around the lungs (pleural effusion). The goal is to see if this test can diagnose tuberculous pleurisy more accurately than current tests. Researchers will study 400 adu…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
One-Shot knee injection could ease arthritis pain
Symptom relief Recruiting nowThis study tests a single injection called 4P004 for people with knee osteoarthritis and synovitis (inflammation). About 129 adults aged 40-80 will receive either the injection or a placebo. The goal is to see if it reduces daily knee pain and improves function over 12 weeks.
Phase: PHASE2 • Sponsor: 4Moving Biotech • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Light therapy shines as potential Drug-Free knee pain relief
Symptom relief Recruiting nowThis study tests whether a special light (810 nm) can reduce knee pain and swelling in people with chronic knee pain and synovitis. About 80 adults aged 40-80 will receive either real light therapy or a sham treatment twice a week for five weeks. Researchers will measure pain, ul…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Could a common arthritis drug ease knee osteoarthritis pain?
Symptom relief Recruiting nowThis study tests whether methotrexate, a drug used for rheumatoid arthritis, can reduce pain and swelling in people with knee osteoarthritis who also have joint inflammation (synovitis). Seventy adults aged 40–70 will receive either methotrexate or a placebo for 6 months. Researc…
Phase: PHASE2 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Symptom relief
Last updated Jun 26, 2026 16:29 UTC
-
Scientists probe immune secrets of tuberculosis to find better treatments
Knowledge-focused Recruiting nowThis study looks at how different types of mycobacterial infections, including drug-resistant tuberculosis and nontuberculous mycobacteria, change the body's immune response. Researchers will collect blood and other samples from 120 participants, including healthy people and thos…
Sponsor: First Affiliated Hospital of Ningbo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Can we predict RA flares? new study watches remission patients for clues
Knowledge-focused Recruiting nowThis study follows 200 adults with rheumatoid arthritis who are already in stable remission from standard medications. Researchers will track their health over up to 5 years using exams, ultrasound, and X-rays to see who stays well and who has a flare. The goal is to learn how to…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Scientists track prednisolone levels to improve dosing for inflammatory conditions
Knowledge-focused Recruiting nowThis pilot study is measuring prednisolone levels in 120 people with inflammatory diseases like thyroid eye disease, vasculitis, COPD, asthma, and others. Participants take high-dose prednisolone as part of their routine care, and researchers take timed blood samples to see how t…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
When to boost? new trial seeks best COVID-19 shot timing for vulnerable patients
Knowledge-focused Recruiting nowThis study looks at 320 adults who are about to start strong immune-suppressing therapy and have already had at least two COVID-19 shots. Researchers want to find out if giving a COVID-19 booster right before starting therapy or waiting six months provides better protection. Part…
Phase: PHASE3 • Sponsor: Kirby Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New study seeks to unlock immune secrets behind deadly fungal infections in ICU patients
Knowledge-focused Recruiting nowThis study looks at how the immune system responds in critically ill patients with severe abdominal infections. Researchers want to understand why some patients develop a serious fungal infection while others do not. They will measure a specific immune marker (HLA-DR) in 100 adul…
Sponsor: Central Hospital, Nancy, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New index may predict sepsis death risk
Knowledge-focused Recruiting nowThis study is testing whether a new measure called the Capillary Leak Index (CLI) can better predict death within 28 days in patients with severe abdominal infection after surgery. Researchers will compare CLI to standard blood tests in 100 adults in the ICU. The goal is to impro…
Sponsor: Benha University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Real-World watch: is zavicefta safe for tough infections?
Knowledge-focused Recruiting nowThis study observes 600 patients in Korea who receive Zavicefta for complicated abdominal or urinary tract infections or hospital-acquired pneumonia. Researchers track side effects and how well the drug works. It is required by Korean regulators to ensure the drug's safety after …
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:53 UTC